Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
SAB Biotherapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
3
| Sessa Capital (Master), L.P. (Director) has filed a Form 3 on SAB Biotherapeutics, Inc. |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2023 |
4
| Lucera Erick (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.465, valued at
$11.6k
|
|
| 04/05/2023 |
3
| Lucera Erick (Director) has filed a Form 3 on SAB Biotherapeutics, Inc. |
| 03/16/2023 |
4
| Kropotova Alexandra (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 275,000 shares
@ $0 |
|
| 03/16/2023 |
4
| Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 525,000 options to buy
@ $0.54, valued at
$283.5k
|
|
| 03/16/2023 |
4
| Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 525,000 options to buy
@ $0.54, valued at
$283.5k
|
|
| 03/16/2023 |
4
| Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.54, valued at
$148.5k
|
|
| 03/16/2023 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.54, valued at
$148.5k
|
|
| 03/02/2023 |
4
| Spragens Jeffrey G (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Acquired 19,936 warrants
@ $11.5, valued at
$229.3k
|
|
| 03/02/2023 |
4
| Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Disposed of 208,600 warrants
@ $11.5, valued at
$2.4M
Acquired 9,968 warrants
@ $11.5, valued at
$114.6k
|
|
| 12/09/2022 |
4
| HAMILTON CHRISTINE E (10% Owner) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 82,987 shares
@ $1.205, valued at
$100k
Granted 82,987 options to buy
@ $1.08, valued at
$89.6k
|
|
| 12/09/2022 |
4
| Spragens Jeffrey G (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 82,987 shares
@ $1.205, valued at
$100k
Granted 82,987 options to buy
@ $1.08, valued at
$89.6k
|
|
| 12/09/2022 |
4
| Link David Charles (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 41,493 shares
@ $1.205, valued at
$50k
Granted 41,493 options to buy
@ $1.08, valued at
$44.8k
|
|
| 09/15/2022 |
4
| Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 525,000 options to buy
@ $0.71, valued at
$372.8k
|
|
| 09/15/2022 |
4
| Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $0.71, valued at
$24.9k
|
|
| 09/15/2022 |
4
| Giberson Scott (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.71, valued at
$17.8k
|
|
| 09/15/2022 |
4
| Kropotova Alexandra (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 18,325 options to buy
@ $0.71, valued at
$13k
|
|
| 09/15/2022 |
4
| Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 274,875 options to buy
@ $0.71, valued at
$195.2k
|
|
| 09/15/2022 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 274,875 options to buy
@ $0.71, valued at
$195.2k
|
|
| 09/14/2022 |
4
| HAMILTON CHRISTINE E (10% Owner) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.7297, valued at
$7.3k
|
|
| 09/08/2022 |
4
| Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Bought 14,000 shares
@ $0.7368, valued at
$10.3k
|
|
| 07/13/2022 |
3
| Giberson Scott (Director) has filed a Form 3 on SAB Biotherapeutics, Inc. |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Disposed of 2,500,127 shares
@ $0
Acquired 207,001 shares
@ $0 |
|
| 03/18/2022 |
4
| Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 21,218 options to buy
@ $1.78, valued at
$37.8k
|
|
| 03/18/2022 |
4
| Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 6,000 options to buy
@ $1.78, valued at
$10.7k
|
|
| 03/18/2022 |
4
| Luke Thomas Charles (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 20,519 options to buy
@ $1.78, valued at
$36.5k
|
|
| 03/18/2022 |
4
| Finnegan Frederick (Chief Business Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 23,453 options to buy
@ $1.78, valued at
$41.7k
|
|
| 03/18/2022 |
4
| Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 7,000 options to buy
@ $1.78, valued at
$12.5k
|
|
| 03/18/2022 |
4
| Ullerich Melissa Vera (Chief Communications Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 16,405 options to buy
@ $1.78, valued at
$29.2k
|
|
| 03/18/2022 |
4
| Pommer Jerry Lynn (Chief Compliance Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 15,172 options to buy
@ $1.78, valued at
$27k
|
|
|
|
|